- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 32.66M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 35.57M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 34.95M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $2.42M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.35M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $37.26M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $10.79M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $117.37M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $82.23M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $128.26M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $107.15M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $69.77M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $50.53M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $82.23M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $61.53M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $173.79M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $135.39M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $210.41M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $168.59M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.42 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.22 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.46 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.25 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $22.89M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $14.98M |
| Net Income | Q1 2026 · Mar 31, 2026 | $14.9M |
| Net Income | Q1 2026 · Mar 31, 2025 | $7.79M |
| Revenue | Q1 2026 · Mar 31, 2026 | $90.1M |
| Revenue | Q1 2026 · Mar 31, 2025 | $58.34M |